On July 9, 2025, Calidi Biotherapeutics, Inc. held its Annual Meeting where stockholders elected new board directors, ratified the appointment of auditors, approved a reverse stock split (between 1-for-2 and 1-for-19), and increased shares for the 2023 Equity Incentive Plan from 393,780 to 3,393,780.